NCT01655719View on ClinicalTrials.gov

Pioglitazone in Thyroid Cancers

PHASE2CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2017

Conditions
Thyroid Cancers That Contain the PAX8-PPARgamma Fusion Gene
Interventions
DRUG

Pioglitazone

Trial Locations (4)

19104

University of Pennsylvania, Philadelphia

48109

University of Michigan, Ann Arbor

77030

University of Texas MD Anderson Cancer Center, Houston

80045

University of Colorado, Aurora

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Michigan

OTHER

NCT01655719 - Pioglitazone in Thyroid Cancers | Biotech Hunter | Biotech Hunter